NCT04680143View on ClinicalTrials.gov

Systemic Erythropoietin Injection in Patients Having Optic Atrophy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

March 30, 2021

Conditions
Optic Atrophy
Interventions
DRUG

Systemic erythropoietin injection

Systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days).

Trial Locations (1)

Unknown

Alexandria Faculty of Medicine, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT04680143 - Systemic Erythropoietin Injection in Patients Having Optic Atrophy | Biotech Hunter | Biotech Hunter